NATCOPHARM.NSNATCOPHARM.NSNSE
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+7.9%
5Y CAGR+9.1%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+7.9%/yr
vs +14.4%/yr prior
5Y CAGR
+9.1%/yr
Consistent
Acceleration
-6.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $8.23B | +13.1% |
| 2025 | $7.27B | -2.8% |
| 2024 | $7.49B | +14.4% |
| 2023 | $6.54B | +12.0% |
| 2022 | $5.84B | +9.9% |
| 2021 | $5.32B | +31.0% |
| 2020 | $4.06B | +6.3% |
| 2019 | $3.82B | -15.1% |
| 2018 | $4.50B | -28.4% |
| 2017 | $6.28B | - |